Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
0.00
(
0.00%
)
US TECH 100
0.00
(
0.00%
)
Dow Jones
45,476.90
(
0.69%
)
Brent Oil
107.35
(
-0.84%
)
Bitcoin
67,262.30
(
1.98%
)
News Focus
News Focus
Post# of 257308
Next 10
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

jbog

Send PM Follow Ignore
Followers 64
Posts 11871
Boards Moderated 0
Alias Born 07/16/2006

jbog

Re: Rocky3 post# 188106

Wednesday, 03/04/2015 2:25:31 PM

Wednesday, March 04, 2015 2:25:31 PM

Post# of 257308
From Barclay's

Enanta Pharmaceuticals Inc (NASDAQ: ENTA) was rated at Equal-weight with a $35 price target. The firm forecasted "peak WW Viekira Pak sales of $2.5B and see limited room for upside given increasing competition in hep C."
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today